Safety analysis of zolpidem in elderly subjects 80 years of age or older: adverse event monitoring in Japanese subjects

References

• Ancoli-Israel, S. (2009). Sleep and its disorders in aging populations. Sleep Medicine, 10(Suppl 1), S7–S11. doi: 10.1016/j.sleep.2009.07.004
   PubMedGoogle Scholar
• Avidan, A.Y., Fries, B.E., James, M.L., Szafara, K.L., Wright, G.T., & Chervin, R.D. (2005). Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. Journal of the American Geriatrics Society, 53(6), 955–962. doi: 10.1111/j.1532-5415.2005.53304.x
   PubMed Web of Science ®Google Scholar
• Bertisch, S.M., Herzig, S.J., Winkelman, J.W., & Buettner, C. (2014). National use of prescription medications for insomnia: NHANES 1999–2010. Sleep, 37(2), 343–349. doi: 10.5665/sleep.3410
   PubMed Web of Science ®Google Scholar
• Fagerstrom, C., & Hellstrom, A. (2011). Sleep complaints and their association with comorbidity and health-related quality of life in an older population in Sweden. Aging and Mental Health, 15(2), 204–213. doi: 10.1080/13607863.2010.513039
   PubMed Web of Science ®Google Scholar
• Finkle, W.D., Der, J.S., Greenland, S., Adams, J.L., Ridgeway, G., Blaschke, T., … VanRiper, K.B. (2011). Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. Journal of the American Geriatrics Society, 59(10), 1883–1890. doi: 10.1111/j.1532-5415.2011.03591.x
   PubMed Web of Science ®Google Scholar
• Ganzoni, E., Santoni, J.P., Chevillard, V., Sebille, M., & Mathy, B. (1995). Zolpidem in insomnia: A 3-year post-marketing surveillance study in Switzerland. Journal of International Medical Research, 23(1), 61–73.
   PubMed Web of Science ®Google Scholar
• Glass, J., Lanctot, K.L., Herrmann, N., Sproule, B.A., & Busto, U.E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. British Medical Journal, 331(7526), 1169–1173. doi: 10.1136/bmj.38623.768588.47
   Web of Science ®Google Scholar
• Greenblatt, D.J., Harmatz, J.S., Roth, T., Singh, N.N., Moline, M.L., Harris, S.C., & Kapil, R.P. (2013). Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: Results from a single-center, single-dose, randomized, open-label crossover study in healthy adults. Clinical Therapeutics, 35(5), 604–611. doi: 10.1016/j.clinthera.2013.03.007
   PubMed Web of Science ®Google Scholar
• Greenblatt, D.J., Harmatz, J.S., & Shader, R.I. (2011). Psychotropic drug prescribing in the United States: Extent, costs, and expenditures. Journal of Clinical Psychopharmacology, 31(1), 1–3. doi: 10.1097/JCP.0b013e318209cf05
   PubMed Web of Science ®Google Scholar
• Greenblatt, D.J., Harmatz, J.S., Singh, N.N., Steinberg, F., Roth, T., Moline, M.L., … Kapil, R.P. (2014). Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. Journal of Clinical Pharmacology, 54(3), 282–290. doi: 10.1002/jcph.220
   PubMed Web of Science ®Google Scholar
• Greenblatt, D.J., & Roth, T. (2012). Zolpidem for insomnia. Expert Opinion on Pharmacotherapy, 13(6), 879–893. doi: 10.1517/14656566.2012.667074
   PubMed Web of Science ®Google Scholar
• Gustavsen, I., Bramness, J.G., Skurtveit, S., Engeland, A., Neutel, I., & Morland, J. (2008). Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Medicine, 9(8), 818–822. doi: 10.1016/j.sleep.2007.11.011
   PubMed Web of Science ®Google Scholar
• Ilomaki, J., Paljarvi, T., Korhonen, M.J., Enlund, H., Alderman, C.P., Kauhanen, J., & Bell, J.S. (2013). Prevalence of concomitant use of alcohol and sedative–hypnotic drugs in middle and older aged persons: A systematic review. Annals of Pharmacotherapy, 47(2), 257–268. doi: 10.1345/aph.1R449
   PubMed Web of Science ®Google Scholar
• The Japanese Pharmaceutical Association. (2009). Summary report of the Drug Event Monitoring project in the 2008/9 financial year. Journal of the Japanese Pharmaceutical Association, 61(11), 1337–1345.
   Google Scholar
• Kajiwara, A., Saruwatari, J., Sakata, M., Morita, K., Kita, A., Oniki, K., … Nakagawa, K. (2013). Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: A questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture. Drug Safety, 36(10), 981–987. doi: 10.1007/s40264-013-0077-z
   PubMed Web of Science ®Google Scholar
• Lai, M.M., Lin, C.C., Lin, C.C., Liu, C.S., Li, T.C., & Kao, C.H. (2014). Long-term use of zolpidem increases the risk of major injury: A population-based cohort study. Mayo Clinic Proceeding, 89(5), 589–594. doi: 10.1016/j.mayocp.2014.01.021
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. (2005). State-of-the-science conference statement on manifestations and management of chronic insomnia in adults. NIH Consensus and State-of-the-Science Statements, 22(2), 1–30.
   Google Scholar
• Neutel, C.I., Skurtveit, S., & Berg, C. (2012). What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Medicine, 13(7), 893–897. doi: 10.1016/j.sleep.2011.12.014
   PubMed Web of Science ®Google Scholar
• Olubodun, J.O., Ochs, H.R., von Moltke, L.L., Roubenoff, R., Hesse, L.M., Harmatz, J.S., … Greenblatt, D.J. (2003). Pharmacokinetic properties of zolpidem in elderly and young adults: Possible modulation by testosterone in men. British Journal of Clinical of Pharmacology, 56(3), 297–304.
   PubMed Web of Science ®Google Scholar
• Rhalimi, M., Helou, R., & Jaecker, P. (2009). Medication use and increased risk of falls in hospitalized elderly patients: A retrospective, case-control study. Drugs and Aging, 26(10), 847–852. doi: 10.2165/11317610-000000000-00000
   PubMed Web of Science ®Google Scholar
• Salva, P., & Costa, J. (1995). Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clinical Pharmacokinetics, 29(3), 142–153. doi: 10.2165/00003088-199529030-00002
   PubMed Web of Science ®Google Scholar
• Stone, K.L., Ancoli-Israel, S., Blackwell, T., Ensrud, K.E., Cauley, J.A., Redline, S., … Cummings, S.R. (2008). Actigraphy-measured sleep characteristics and risk of falls in older women. Archives of Internal Medicine, 168(16), 1768–1775. doi: 10.1001/archinte.168.16.1768
   PubMed Web of Science ®Google Scholar
• Weich, S., Pearce, H.L., Croft, P., Singh, S., Crome, I., Bashford, J., & Frisher, M. (2014). Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: Retrospective cohort study. British Medical Journal, 348, g1996. doi: 10.1136/bmj.g1996
   PubMed Web of Science ®Google Scholar